American Oncology Network Inc

American Oncology Network Inc has a debt-to-equity ratio of 1.36, indicating a moderate level of leverage, while its current ratio of 1.69 suggests it has sufficient short-term assets to cover its liabilities. The company's liquidity position is assessed as medium, with negative free cash flow of -$1.96 million and operating cash flow of -$329,000, signaling potential challenges in maintaining operational liquidity.

Profitability metrics show a return on equity of -2.45% and a return on assets of -0.44%, both significantly below the industry median for healthcare facilities and services. The company reported a net loss of $1.49 million and an operating loss of $491,000, indicating a lack of profitability compared to industry peers.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic or regulatory shifts that could impact its operations.

The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year. The absence of positive revenue growth, combined with negative operating and net income, suggests a challenging operating environment.

Risk factors include a medium liquidity risk due to negative free cash flow and a debt load that exceeds equity. The company has a low dilution risk, with no near-term pressure for additional equity issuance. However, the negative net cash position after subtracting total debt raises concerns about its ability to meet long-term obligations.

Recent filings and transcripts have not disclosed any material events that would significantly alter the company's financial or operational outlook. The company remains in a loss-making position, with no clear path to profitability in the near term.

Revenue grew 37.5% year-over-year to $1.76 billion, demonstrating strong top-line expansion momentum.

Operating income improved 64.5% year-over-year, indicating significant progress in operational efficiency and cost management.

Free cash flow improved 38.7% year-over-year, showing better cash generation despite ongoing negative absolute values.

Long-term debt decreased from $86.4 million to $95.5 million over the period, though recent trends show reduction.

Gross profit reached $117.8 million, providing a substantial base for potential operating leverage improvements.

The company carries a high credit risk flag, signaling significant concerns regarding its ability to meet obligations.

Net margin of -0.49% remains well below the 4.15% cohort median, highlighting persistent profitability challenges.

Debt-to-equity ratio of 1.36 is in the bottom quartile, indicating excessive leverage compared to peers.

Free cash flow remains negative at -$43.1 million, creating reliance on external financing for operations.